Article
The influence of genetic RFC1, MS and MTHFR polymorphisms on the risk of acute lymphoblastic leukemia relapse in children and the adverse effects of methotrexate.
Advances in clinical and experimental medicine : official organ Wroclaw Medical University - 1 Jan 2000
Niedzielska Ewa, Węcławek-Tompol Jadwiga, Matkowska-Kocjan Agnieszka, Chybicka Alicja
Abstract excerpt
Polymorphism in genes coding drug-metabolizing enzymes may cause individual differences in the effectiveness and toxicity of many medications, including cytostatics. Although in recent years intensive treatment has positively influenced the prognosis in leukemias, many adverse effects resulting from nonspecific actions and the narrow therapeutic index of anti-cancer drugs are still observed during therapy....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
